Autoimmune Hepatitis Clinical Trials

14 recruiting

Autoimmune Hepatitis Trials at a Glance

14 actively recruiting trials for autoimmune hepatitis are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Not Applicable with 1 trial, with the heaviest enrollment activity in Cincinnati, London, and Hamilton. Lead sponsors running autoimmune hepatitis studies include Children's Hospital Medical Center, Cincinnati, University Health Network, Toronto, and Elizabeth C. Verna.

Browse autoimmune hepatitis trials by phase

Treatments under study

About Autoimmune Hepatitis Clinical Trials

Looking for clinical trials for Autoimmune Hepatitis? There are currently 14 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Autoimmune Hepatitis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Autoimmune Hepatitis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 114 of 14 trials

Recruiting
Phase 2

Belimumab in Autoimmune Hepatitis

Autoimmune Hepatitis
University Health Network, Toronto48 enrolled5 locationsNCT06381453
Recruiting

Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome

Non-Alcoholic Fatty Liver DiseaseAutoimmune HepatitisPrimary Sclerosing Cholangitis+2 more
Chungnam National University Hospital3,000 enrolled1 locationNCT06519162
Recruiting
Phase 1

A Study of SIPLIZUMAB in AILD and LT Patients

Autoimmune HepatitisPrimary Sclerosing CholangitisLiver Transplant Disorder+1 more
Elizabeth C. Verna8 enrolled1 locationNCT06455280
Recruiting

Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation

Autoimmune HepatitisSystemic Lupus ErythematosusHemophagocytic Lymphohistiocytoses+17 more
Institut National de la Santé Et de la Recherche Médicale, France500 enrolled1 locationNCT04902807
Recruiting

Swiss Autoimmune Hepatitis Cohort Study

Autoimmune HepatitisHepatitis, Autoimmune
Fondazione Epatocentro Ticino500 enrolled20 locationsNCT03146884
Recruiting

A-LiNK: Improving Outcomes in Autoimmune Liver Disease

Autoimmune HepatitisPrimary Sclerosing Cholangitis
Children's Hospital Medical Center, Cincinnati800 enrolled8 locationsNCT05750498
Recruiting
Not Applicable

Mediterranean Diet Versus Western Diet on Fatigue in Autoimmune Hepatitis Patients

Autoimmune Hepatitis
Indiana University48 enrolled1 locationNCT06250309
Recruiting

MRI Based Biomarkers in Pediatric Autoimmune Liver Disease

Autoimmune HepatitisPrimary Sclerosing CholangitisAutoimmune Liver Disease
Children's Hospital Medical Center, Cincinnati115 enrolled1 locationNCT03175471
Recruiting

MRI Biomarkers in as Predictor of Clinical Endpoints in Pediatric Autoimmune Liver Disease

Autoimmune HepatitisPrimary Sclerosing CholangitisAutoimmune Liver Disease
Children's Hospital Medical Center, Cincinnati150 enrolled1 locationNCT03178630
Recruiting

PredIcting SterOid DepeNdEnt LivEr InjuRy with Polyreactive Immunoglobulin G

Autoimmune HepatitisAutoimmune Liver Disease
Hannover Medical School200 enrolled8 locationsNCT05810480
Recruiting

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

CancerLymphomaLeukemia+44 more
Sanguine Biosciences20,000 enrolled1 locationNCT05635266
Recruiting

Development of a Autoimmune Hepatitis Patient's Database Linked to a Biological Sample Storage

Autoimmune HepatitisLiver Disorder
University of Milano Bicocca10,000 enrolled1 locationNCT06078098
Recruiting

Autoimmune Hepatitis Cohort in China

Autoimmune Hepatitis
Shanghai Jiao Tong University School of Medicine1,000 enrolled1 locationNCT05785793
Recruiting

Canadian Network for Autoimmune Liver Disease

Autoimmune HepatitisOverlap SyndromePrimary Bilary Cirrhosis (PBC)
University Health Network, Toronto2,500 enrolled15 locationsNCT03569826